Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
Currently, strong evidence has been obtained for the fundamental role of pathological activation of B cells in the pathogenesis of immunoinflammatory (autoimmune) rheumatic diseases (IMRD), and drugs that specifically modulate the function or cause depletion of various subpopulations of B cells and...
Sábháilte in:
| Príomhchruthaitheoirí: | , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe / Cruthaithe: |
IMA PRESS LLC
2021-09-01
|
| Sraith: | Научно-практическая ревматология |
| Ábhair: | |
| Rochtain ar líne: | https://rsp.mediar-press.net/rsp/article/view/3053 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|